These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38482096)

  • 41. Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.
    Fontán-Vela M; Hernando V; Olmedo C; Coma E; Martínez M; Moreno-Perez D; Lorusso N; Vázquez Torres M; Barbas Del Buey JF; Roig-Sena J; Pastor E; Galmés Truyols A; Artigues Serra F; Sancho Martínez RM; Latasa Zamalloa P; Pérez Martínez O; Vázquez Estepa A; García Rojas AJ; Barreno Estévez AI; Sánchez-Migallón Naranjo A; Pérez Martín JJ; Peces Jiménez P; Morales Romero R; Castilla J; García Cenoz M; Huerta Huerta M; Boone ALD; Macías Ortiz MJ; Álvarez Río V; Rodríguez Recio MJ; Merino Díaz M; Berradre Sáenz B; Villegas-Moreno MT; Limia A; Diaz A; Monge S;
    Clin Infect Dis; 2024 Feb; 78(2):476-483. PubMed ID: 37864849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse event reports following vaccination for Lyme disease: December 1998-July 2000.
    Lathrop SL; Ball R; Haber P; Mootrey GT; Braun MM; Shadomy SV; Ellenberg SS; Chen RT; Hayes EB
    Vaccine; 2002 Feb; 20(11-12):1603-8. PubMed ID: 11858868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013.
    Sukumaran L; McNeil MM; Moro PL; Lewis PW; Winiecki SK; Shimabukuro TT
    Clin Infect Dis; 2015 May; 60(10):e58-65. PubMed ID: 25637587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994.
    Braun MM; Ellenberg SS
    J Pediatr; 1997 Oct; 131(4):529-35. PubMed ID: 9386653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
    Farrar JL; Lewis NM; Houck K; Canning M; Fothergill A; Payne AB; Cohen AL; Vance J; Brassil B; Youngkin E; Glenn B; Mangla A; Kupferman N; Saunders K; Meza C; Nims D; Soliva S; Blouse B; Henderson T; Banerjee E; White B; Birn R; Stadelman AM; Abrego M; McLafferty M; Eberhart MG; Pietrowski M; De León SM; Creegan E; Diedhiou A; Wiedeman C; Murray-Thompson J; McCarty E; Marcinkevage J; Kocharian A; Torrone EA; Ray LC; Payne DC;
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(5152):1610-1615. PubMed ID: 36580416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
    Moro PL; Arana J; Marquez PL; Ng C; Barash F; Hibbs BF; Cano M
    Vaccine; 2019 Jun; 37(28):3730-3734. PubMed ID: 31155414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What determines mpox vaccination uptake? Assessing the effect of intent-to-vaccinate versus other determinants among men who have sex with men.
    Jongen VW; Groot Bruinderink ML; Boyd A; Koole JCD; Teker B; Dukers-Muijrers NHTM; Evers YJ; Schim van der Loeff MF; Prins M; de Vries HJC; Matser A; Davidovich U
    Vaccine; 2024 Jan; 42(2):186-193. PubMed ID: 38072753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System.
    Nyankerh CNA; Boateng AK; Appah M
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
    Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
    Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis.
    Singh RB; Parmar UPS; Kahale F; Agarwal A; Tsui E
    Ophthalmology; 2023 Feb; 130(2):179-186. PubMed ID: 36055601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modifications to Sexual Behaviors Associated With Mpox (Monkeypox) Virus Transmission Among Persons Presenting for mpox Vaccination, Washington, DC, August-October, 2022.
    Copen CE; Delaney KP; Agnew-Brune C; Berry I; Griffin I; Hassan R; Oakley LP; Wondmeneh S; Rhodes T; Gillani S; Lee M; Ashley P; Willut C; Mangla AT; Waltenburg MA; Jackson DA;
    Sex Transm Dis; 2024 Jan; 51(1):54-60. PubMed ID: 37889944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database.
    Geier DA; Geier MR
    Immunol Res; 2017 Feb; 65(1):46-54. PubMed ID: 27406735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown.
    Vairo F; Leone S; Mazzotta V; Piselli P; De Carli G; Lanini S; Maggi F; Nicastri E; Gagliardini R; Vita S; Siddu A; Rezza G; Barca A; Vaia F; Antinori A; Girardi E
    Int J Infect Dis; 2023 May; 130():83-85. PubMed ID: 36906119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mpox vaccine acceptability among people experiencing homelessness in San Francisco - October-November 2022.
    Filardo TD; Prasad N; Waddell CJ; Persad N; Pellegrini GJ; Borne D; Janssen J; Bejarano A; Marx GE; Mosites E
    Vaccine; 2023 Sep; 41(39):5673-5677. PubMed ID: 37591706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.
    Myers TR; McNeil MM; Ng CS; Li R; Lewis PW; Cano MV
    Vaccine; 2017 Mar; 35(14):1758-1763. PubMed ID: 28262331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mpox (Monkeypox) and the Eye: Ocular Manifestation, Diagnosis, Treatment and Vaccination.
    Zong Y; Kamoi K; Zhang J; Yang M; Ohno-Matsui K
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
    Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A survey-based assessment of rates and covariates of mpox diagnosis and vaccination provides evidence to refine eligibility criteria for mpox vaccination among gay, bisexual and other men who have sex with men in the Netherlands.
    Adam PCG; Op de Coul ELM; Zantkuijl P; Xiridou M; Bos H; Blom C; Ketsuwan I; Te Wierik MJM; David S; de Wit JBF
    Front Public Health; 2024; 12():1194844. PubMed ID: 38351958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
    Aden D; Zaheer S; Kumar R; Ranga S
    J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse Reactions After Intradermal Vaccination With JYNNEOS for Mpox in Korea.
    Lim SY; Jung YM; Kim Y; Kim G; Jeon J; Chin B; Kim MK
    J Korean Med Sci; 2024 Mar; 39(8):e100. PubMed ID: 38442725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.